Endo is expected to have full ownership of the compounds developed under the collaboration with exclusive worldwide rights, and will fund all subsequent drug development and commercialisation activities.
Dale VanderPutten, CEO of Omnia, said: “Vladimir Slepushkin and his team’s breadth of experience in biologics from R&D through clinical development in a wide variety disease targets and
Corvert injection (Ibutilide fumarate injection) is an antiarrhythmic drug with predominantly class III (cardiac action potential prolongation) properties according to the Vaughan Williams Classification. Each milliliter of Corvert
The agreement includes distribution in the US, Canada and Puerto Rico, and expands Sigma-Aldrich’s portfolio of chromatography solutions offered through its Supelco brand. In addition to the classic
XRX-001 is an inactivated virus vaccine adsorbed to alum adjuvant. As it is inactivated and non-replicating, it is anticipated to reduce the risks of serious and fatal adverse
Taxol, a first line chemotherapy drug used to treat breast, lung and ovarian cancers, is currently administered through an intravenous infusion that can take up to 24 hours
Reportedly, the MAA submission and Canadian NDS are based on a comprehensive development program including results from two Phase III, randomised, double-blind, placebo-controlled studies. These studies demonstrated the
The suspension of operations at the facility is expected to reduce operating costs by approximately $20m in 2010, with an annualised run-rate of approximately $25m. As a result
The acquisition of MRT, with its patented approach to high throughput miniature bioreactor equipment and disposables, expands Pall’s Total Fluid Management(TFM) capabilities in the $1 billion biopharmaceuticals process
The new line produces high-performance polyester films, which will support the fast growing UK market. Klockner Pentaplast invested £3 Mio (E3.4 Mio /$4.4 Mio) for the expansion, with
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.